Evidence map›Paper›PMID 37389244›Full record

ArticleChemical science2023

Development of a nitrogen-bound hydrophobic auxiliary: application to solid/hydrophobic-tag relay synthesis of calpinactam.

Hiroki Nakahara, Goh Sennari, Yoshihiko Noguchi, Tomoyasu Hirose, Toshiaki Sunazuka

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroki NakaharaŌmura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan thirose@lisci.kitasato-u.ac.jp sunazuka@lisci.kitasato-u.ac.jp.ORCID https://orcid.org/0009-0002-6472-2398
Goh SennariŌmura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan thirose@lisci.kitasato-u.ac.jp sunazuka@lisci.kitasato-u.ac.jp.ORCID https://orcid.org/0000-0003-4347-7522
Yoshihiko NoguchiŌmura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan thirose@lisci.kitasato-u.ac.jp sunazuka@lisci.kitasato-u.ac.jp.ORCID https://orcid.org/0000-0002-7027-5822
Tomoyasu HiroseŌmura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan thirose@lisci.kitasato-u.ac.jp sunazuka@lisci.kitasato-u.ac.jp.ORCID https://orcid.org/0000-0002-9463-8181
Toshiaki SunazukaŌmura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan thirose@lisci.kitasato-u.ac.jp sunazuka@lisci.kitasato-u.ac.jp.ORCID https://orcid.org/0000-0003-2538-9916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last couple of decades, technologies and strategies for peptide synthesis have advanced rapidly. Although solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) have contributed significantly to the development of the field, there have been remaining challenges for C-terminal modifications of peptide compounds in SPPS and LPPS. Orthogonal to the current standard approach that relies on installation of a carrier molecule at the C-terminus of amino acids, we developed a new hydrophobic-tag carbonate reagent which facilitated robust preparation of nitrogen-tag-supported peptide compounds. This auxiliary was easily installed on a variety of amino acids including oligopeptides that have a broad range of noncanonical residues, allowing simple purification of the products by crystallization and filtration. We demonstrated a

Identifiers

PMID37389244
PMCPMC10306108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.